National Registry for Robotically Assisted Surgery

The contract for the Robotically Assisted Surgery Registry will initially be delivered for NHS-funded care in England, for a period of 3 years, at a maximum total budget of up to PS1,050,000 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years.

This extension period, if decided, will be invoked under one of the below options 1)A funded extension at a pro rata cost of the first 3 years 2)The successful bidder, working with the Authority to develop a self-sustaining funding model for the continuation of the registry Please note that the Authority cannot guarantee that an extension will be granted. The maximum budget 'core' value is PS1,050,000 excluding VAT. This excludes the potential two-year extension and aspirational intent which will be included in the service specification at point of tender.

The role of a national registry is to provide high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. This registry is expected to: Provide information to improve patient safety and outcomes by tracking short- and long-term results of robotic-assisted surgery, evaluate effectiveness and value of robotic-assisted surgery compared with conventional techniques, support standardisation of practice and identify variation in surgical outcomes across hospitals and surgeons, provide evidence to inform clinical guidelines, commissioning, and regulatory decisions and facilitate research and innovation in robotic surgical technologies and techniques.

National registries are expected to: a.Develop a robust, high-quality registry designed around key quality metrics as laid out in NICE EVA b.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the establishment of the registry, as appropriate c.Enable the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting d.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the registry e.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract f.Ensure robust methodological and statistical input at all stages of the audit g.Identify from the outset the full range of audiences for any reports and other registry outputs, and plan and tailor them accordingly h.Provide results in a timely, accessible and meaningful manner minimising the reporting delay and providing continual access to each stakeholder for their own data i.Utilise strong and effective project and programme management to deliver outputs on time and within budget j.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups in order to drive improvements in services Further details of NICE Early Value Assessment (EVA) process and methods can be found at: nice.org.uk/what-nice-does/our-guidance/about-medical-tec... For more information about this opportunity, please visit the Delta eSourcing portal at: delta-esourcing.com/tenders/UK-UK-London:-Health-services... To respond to this opportunity, please click here: delta-esourcing.com/respond/J3EC5N6DAH